Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132(Pt 2):288-295

Neural Regeneration, Institute of Reconstructive Neurobiology, University Bonn and Hertie-Foundation, Bonn, Germany.
Brain (Impact Factor: 9.2). 07/2008; 132(Pt 2):288-95. DOI: 10.1093/brain/awn109
Source: PubMed

ABSTRACT Microglia are cells of myeloid origin that populate the CNS during early development and form the brain's innate immune cell type. They perform homoeostatic activity in the normal CNS, a function associated with high motility of their ramified processes and their constant phagocytic clearance of cell debris. This debris clearance role is amplified in CNS injury, where there is frank loss of tissue and recruitment of microglia to the injured area. Recent evidence suggests that this phagocytic clearance following injury is more than simply tidying up, but instead plays a fundamental role in facilitating the reorganization of neuronal circuits and triggering repair. Insufficient clearance by microglia, prevalent in several neurodegenerative diseases and declining with ageing, is associated with an inadequate regenerative response. Thus, understanding the mechanism and functional significance of microglial-mediated clearance of tissue debris following injury may open up exciting new therapeutic avenues.

Download full-text


Available from: Mark R Kotter, May 07, 2014
1 Follower
30 Reads
  • Source
    • "Inhibition of c - Src Prevents Microgliosis and Apoptosis in the Retina In Vivo Fast and dynamic changes in microglia to a more amoeboid cell morphology is commonly associated with increased phag - ocytic activity ( Neumann et al . , 2009 ) . c - Src itself has been implicated in regulating the phagocytic activity of glial cells in Drosophila ( Ziegenfuss et al . , 2008 ) , and we show that exposure of primary microglial cells to LPS significantly increased phagocytosis of latex microbeads ( Fig . 5A ) . Such effect was abrogated either by c - Src inhibition with SKI - 1"
    [Show abstract] [Hide abstract]
    ABSTRACT: Microglial cells are the resident macrophages of the central nervous system (CNS). Their function is essential for neuronal tissue homeostasis. After inflammatory stimuli, microglial cells become activated changing from a resting and highly ramified cell shape to an amoeboid-like morphology. These morphological changes are associated with the release of pro-inflammatory cytokines and glutamate, as well as with high phagocytic activity. The acquisition of such phenotype has been associated with activation of cytoplasmic tyrosine kinases, including those of the Src family (SFKs). In this study, using both in vivo and in vitro inflammation models coupled to FRET-based time-lapse microscopy, lentiviruses-mediated shRNA delivery and genetic gain-of-function experiments, we demonstrate that among SFKs c-Src function is necessary and sufficient for triggering microglia pro-inflammatory signature, glutamate release, microglia-induced neuronal loss and phagocytosis. c-Src inhibition in retinal neuroinflammation experimental paradigms consisting of intravitreal injection of LPS or ischemia-reperfusion injury significantly reduced microglia activation changing their morphology to a more resting phenotype and prevented neuronal apoptosis. Our data demonstrate an essential role for c-Src in microglial cell activation.
    Glia 03/2015; 63(3). DOI:10.1002/glia.22767 · 6.03 Impact Factor
  • Source
    • "In addition, the idea of modifying the disease environment surrounding mDA neurons is appearing on the therapeutic horizon. Glial cells can produce both detrimental and beneficial environments in the central nervous system (CNS), and these are associated with the release of pro-inflammatory and antiinflammatory (or neurotrophic) cytokines, respectively (reviewed in reference Neumann et al, 2009). Thus a strategy biasing toward beneficial glial cells could be a promising therapeutic approach in PD. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Use of the physiological mechanisms promoting midbrain DA (mDA) neuron survival seems an appropriate option for developing treatments for Parkinson's disease (PD). mDA neurons are specifically marked by expression of the transcription factors Nurr1 and Foxa2. We show herein that Nurr1 and Foxa2 interact to protect mDA neurons against various toxic insults, but their expression is lost during aging and degenerative processes. In addition to their proposed cell-autonomous actions in mDA neurons, forced expression of these factors in neighboring glia synergistically protects degenerating mDA neurons in a paracrine mode. As a consequence of these bimodal actions, adeno-associated virus (AAV)-mediated gene delivery of Nurr1 and Foxa2 in a PD mouse model markedly protected mDA neurons and motor behaviors associated with nigrostriatal DA neurotransmission. The effects of the combined gene delivery were dramatic, highly reproducible, and sustained for at least 1 year, suggesting that expression of these factors is a promising approach in PD therapy. © 2015 The Authors. Published under the terms of the CC BY 4.0 license.
    EMBO Molecular Medicine 03/2015; 7(5). DOI:10.15252/emmm.201404610 · 8.67 Impact Factor
  • Source
    • "We provided evidence of the transient and focal nature of altered vascular permeability in early EAE induction as an initiating event, not a byproduct of effector T cell aggregation and tissue destruction near the perivascular pathologic lesions. These leaks occurred during PTx treatment, where blood contents including plasma proteins and fibrinogen (Davalos et al., 2012) are released into the parenchyma and initiate a parenchymal inflammatory response including the activation of the phagocytic capacity of resident CX 3 CR1 + microglia (Neumann et al., 2009), well in advance of any observable clinical symptoms. Vessel leaks were found in the meninges and throughout the parenchyma. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Peripheral immune cells are critical to the pathogenesis of neurodegenerative diseases including multiple sclerosis (MS) (Hendriks et al., 2005; Kasper and Shoemaker, 2010). However, the precise sequence of tissue events during the early asymptomatic induction phase of experimental autoimmune encephalomyelitis (EAE) pathogenesis remains poorly defined. Due to the spatial-temporal constrains of traditional methods used to study this disease, most studies had been performed in the spine during peak clinical disease; thus the debate continues as to whether tissue changes such as vessel disruption represents a cause or a byproduct of EAE pathophysiology in the cortex. Here, we provide dynamic, high-resolution information on the evolving structural and cellular processes within the grey matter of the mouse cortex during the first 12 asymptomatic days of EAE induction. We observed that transient focal vessel disruptions precede microglia activation, followed by infiltration of and directed interaction between circulating dendritic cells and T cells. Histamine antagonist minimizes but not completely ameliorates blood vessel leak. Histamine H1 receptor blockade prevents early microglia function, resulting in subsequent reduction in immune cell accumulation, disease incidence and clinical severity. Copyright © 2015. Published by Elsevier Inc.
    Experimental Neurology 02/2015; 111. DOI:10.1016/j.expneurol.2015.02.018 · 4.70 Impact Factor
Show more